# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Clorox CEO Linda Rendle "has done a remarkable job, let's understand that," Cramer said. "She was not delivered...
Barclays analyst Lauren Lieberman maintains Clorox (NYSE:CLX) with a Underweight and raises the price target from $122 to $130.
DA Davidson analyst Linda Bolton Weiser maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $162 to ...
JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:CLX) with a Neutral and lowers the price target from $150 to $148.
Deutsche Bank analyst Stephen Powers maintains Clorox (NYSE:CLX) with a Hold and raises the price target from $144 to $151.
Clorox shares are up after the company reported its second-quarter financial results Thursday. Here's a look at the key fig...
Clorox (NYSE:CLX) reported quarterly earnings of $1.82 per share which beat the analyst consensus estimate of $1.56 by 16.67 pe...